. 2017 Sep 19;2017:7648505. doi: 10.1155/2017/7648505

Table 4.

Effects of COE on serum lipid profile in diabetic model mice after 4 weeks of treatment.

Groups	TG (mmol/L)	TC (mmol/L)	HDLC (mmol/L)	LDLC (mmol/L)
NC	1.03 ± 0.38^∗∗	1.81 ± 0.41^∗∗	2.34 ± 0.24^∗∗	0.20 ± 0.05^∗∗
DM	2.06 ± 0.43^ΔΔ	3.27 ± 0.23^ΔΔ	1.28 ± 0.36^ΔΔ	0.44 ± 0.09^ΔΔ
COE-L	1.64 ± 0.23^∗∗^Δ	2.40 ± 0.47^∗∗	1.52 ± 0.37^ΔΔ	0.32 ± 0.09^∗∗^ΔΔ
COE-H	1.35 ± 0.23^∗∗	2.35 ± 0.52^∗∗	2.17 ± 0.28^∗∗	0.23 ± 0.06^∗∗
ROS	1.34 ± 0.53^∗∗	2.14 ± 0.90^∗∗	2.09 ± 0.45^∗∗^Δ	0.27 ± 0.06^∗∗

Data were presented as mean ± standard deviation (n = 8). TG: triglyceride; TC: total cholesterol; HDLC: high-density lipoprotein cholesterol; LDLC: low-density lipoprotein cholesterol. Mice were supplemented with COE at 50 (COE-L) or 200 (COE-H) mg/kg body weight and rosiglitazone at 4 mg/kg body weight (ROS) for 4 weeks. ^∗∗P < 0.01 compared to group DM; ^ΔP < 0.05 and ^ΔΔP < 0.01 compared to group NC.